BRAF and neoplasm: In HCT116, a colon cancer line, that carries a mutant KRAS allele, we find that interfering with the RAF effector axis at the level of RAF (BRAF and CRAF) and MEK (MEK1 and MEK2) was effective in delaying tumor growth.